Skip to content

Author

E. Stolyarevich

We have 3 of 47 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Use of RAAS blockers in patients with malignant hypertension and thrombotic microangiopathy: A series of clinical observations

Malignant arterial hypertension (MAH) is a medical emergency characterized by severe elevation of blood pressure (BP; typically, >180/120 mmHg) accompanied by acute target-organ damage involving the kidneys, central nervous system, eyes, and/or heart. The severity and duration of arterial hypertension are important det...

K. Demyanova, N. Kozlovskaya, M. Khachatryan et al. · 0 citations
Review Open access Sep 2026

Pathogenesis, clinical and histological features of calcineurin inhibitors induced nephrotoxicity: Literature review

Since the 1980s, calcineurin inhibitors (CNI) have been widely used as immunosuppressive agents in solid organ transplantation and in the treatment of immune-mediated glomerular diseases, including complicated nephrotic syndrome. However, CNI-induced nephrotoxicity (CNIT) remains one of the most frequent adverse effect...

A. M. Khokhlova, E. Stolyarevich, L. Prikhodina · 0 citations
Open access Sep 2026

Factors associated with renal response in patients with lupus nephritis: a single‑center retrospective cohort study

Baseline kidney function and the histopathological class of LN are key factors associated with treatment response, and factors associated with renal response after 12 months of treatment are identified.

K. A. Gorchakova, K. V. Kapustina, V. A. Pugach et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.